Disc Medicine
Logotype for Disc Medicine Inc

Disc Medicine (IRON) investor relations material

Disc Medicine Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Disc Medicine Inc
Q4 2025 earnings summary26 Feb, 2026

Executive summary

  • Advanced bitopertin program for EPP, with Phase 3 APOLLO study enrollment to complete in March 2026 and topline data expected Q4 2026.

  • Initial Phase 2 data for DISC-0974 in myelofibrosis anemia showed meaningful responses across all patient subgroups.

  • Progressed Phase 2 study of DISC-3405 in polycythemia vera and initiated Phase 1b in sickle cell disease, with data from both expected in 2H 2026.

Financial highlights

  • Ended Q4 2025 with $791.2 million in cash, cash equivalents, and marketable securities, up from $489.9 million at end of 2024.

  • Net loss for 2025 was $212.2 million, compared to $109.4 million in 2024, driven by higher operating costs.

  • R&D expenses rose to $170.6 million in 2025 from $96.7 million in 2024, reflecting portfolio progression and milestone payments.

  • SG&A expenses increased to $65.4 million in 2025 from $33.0 million in 2024, mainly due to increased headcount and commercialization infrastructure.

Outlook and guidance

  • Cash runway expected to fund operations into 2029.

  • Topline data from APOLLO Phase 3 for bitopertin expected Q4 2026; FDA decision anticipated by mid-2027.

  • Initial data from DISC-3405 studies in PV and SCD expected in 2H 2026.

  • Initial data from Phase 2 study of DISC-0974 in IBD and anemia expected in 2027.

How will APOLLO data address CRL's PPIX concern?
Impact of DISC-0974's JAK inhibitor independence?
SG&A increase given bitopertin CRL timeline?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Disc Medicine earnings date

Logotype for Disc Medicine Inc
TD Cowen 46th Annual Health Care Conference3 Mar, 2026
Disc Medicine
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Disc Medicine earnings date

Logotype for Disc Medicine Inc
TD Cowen 46th Annual Health Care Conference3 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Disc Medicine Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for severe hematologic disorders. Founded as Gemini Therapeutics Inc before evolving into its current form, the company has a pipeline that includes therapies aimed at erythropoietic porphyrias (including erythropoietic protoporphyria and X-linked protoporphyria), Diamond-Blackfan Anemia, anemia of myelofibrosis, chronic kidney disease, and polycythemia vera among others. Disc Medicine's preclinical programs also target anemia associated with inflammatory diseases. The company is headquartered in Watertown, Massachusetts, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage